autologous cd34+-enriched cell fraction strimvelis (Glaxo Smith)
Structured Review

Autologous Cd34+ Enriched Cell Fraction Strimvelis, supplied by Glaxo Smith, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd34++fraction/strimvelis/pmc11222908-222-7-8
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "Development of orphan drugs for rare diseases"
Article Title: Development of orphan drugs for rare diseases
Journal: Clinical and Experimental Pediatrics
doi: 10.3345/cep.2023.00535
Figure Legend Snippet: FDA/EMA approved gene therapy product for rare monogenic diseases
Techniques Used: Plasmid Preparation, In Vivo, Ex Vivo, Mutagenesis, Modification, Variant Assay
Related Articles
Transduction:Article Title: Characteristics of Medical Products Comprising Human Cells, Genes, or Tissues Developed in Japan and the European Union Compared via Public Assessment Reports Article Snippet: , Autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with retroviral vector that encodes for the human ADA cDNA sequence , Strimvelis® , Adenosine deaminase (ADA)-severe Retroviral:Article Title: Characteristics of Medical Products Comprising Human Cells, Genes, or Tissues Developed in Japan and the European Union Compared via Public Assessment Reports Article Snippet: , Autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with retroviral vector that encodes for the human ADA cDNA sequence , Strimvelis® , Adenosine deaminase (ADA)-severe Plasmid Preparation:Article Title: Characteristics of Medical Products Comprising Human Cells, Genes, or Tissues Developed in Japan and the European Union Compared via Public Assessment Reports Article Snippet: , Autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with retroviral vector that encodes for the human ADA cDNA sequence , Strimvelis® , Adenosine deaminase (ADA)-severe Sequencing:Article Title: Characteristics of Medical Products Comprising Human Cells, Genes, or Tissues Developed in Japan and the European Union Compared via Public Assessment Reports Article Snippet: , Autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with retroviral vector that encodes for the human ADA cDNA sequence , Strimvelis® , Adenosine deaminase (ADA)-severe Transplantation Assay:Article Title: Characteristics of Medical Products Comprising Human Cells, Genes, or Tissues Developed in Japan and the European Union Compared via Public Assessment Reports Article Snippet: , Autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with retroviral vector that encodes for the human ADA cDNA sequence , Strimvelis® , Adenosine deaminase (ADA)-severe Virus:Article Title: Characteristics of Medical Products Comprising Human Cells, Genes, or Tissues Developed in Japan and the European Union Compared via Public Assessment Reports Article Snippet: , Autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with retroviral vector that encodes for the human ADA cDNA sequence , Strimvelis® , Adenosine deaminase (ADA)-severe Genetically Modified:Article Title: Characteristics of Medical Products Comprising Human Cells, Genes, or Tissues Developed in Japan and the European Union Compared via Public Assessment Reports Article Snippet: , Autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with retroviral vector that encodes for the human ADA cDNA sequence , Strimvelis® , Adenosine deaminase (ADA)-severe Ex Vivo:Article Title: Characteristics of Medical Products Comprising Human Cells, Genes, or Tissues Developed in Japan and the European Union Compared via Public Assessment Reports Article Snippet: , Autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with retroviral vector that encodes for the human ADA cDNA sequence , Strimvelis® , Adenosine deaminase (ADA)-severe Injection:Article Title: Characteristics of Medical Products Comprising Human Cells, Genes, or Tissues Developed in Japan and the European Union Compared via Public Assessment Reports Article Snippet: , Autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with retroviral vector that encodes for the human ADA cDNA sequence , Strimvelis® , Adenosine deaminase (ADA)-severe Derivative Assay:Article Title: Characteristics of Medical Products Comprising Human Cells, Genes, or Tissues Developed in Japan and the European Union Compared via Public Assessment Reports Article Snippet: , Autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with retroviral vector that encodes for the human ADA cDNA sequence , Strimvelis® , Adenosine deaminase (ADA)-severe Muscles:Article Title: Characteristics of Medical Products Comprising Human Cells, Genes, or Tissues Developed in Japan and the European Union Compared via Public Assessment Reports Article Snippet: , Autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with retroviral vector that encodes for the human ADA cDNA sequence , Strimvelis® , Adenosine deaminase (ADA)-severe Selection:Article Title: Characteristics of Medical Products Comprising Human Cells, Genes, or Tissues Developed in Japan and the European Union Compared via Public Assessment Reports Article Snippet: , Autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with retroviral vector that encodes for the human ADA cDNA sequence , Strimvelis® , Adenosine deaminase (ADA)-severe Clinical Proteomics:Article Title: Characteristics of Medical Products Comprising Human Cells, Genes, or Tissues Developed in Japan and the European Union Compared via Public Assessment Reports Article Snippet: , Autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with retroviral vector that encodes for the human ADA cDNA sequence , Strimvelis® , Adenosine deaminase (ADA)-severe Titration:Article Title: Characteristics of Medical Products Comprising Human Cells, Genes, or Tissues Developed in Japan and the European Union Compared via Public Assessment Reports Article Snippet: , Autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with retroviral vector that encodes for the human ADA cDNA sequence , Strimvelis® , Adenosine deaminase (ADA)-severe Immunopeptidomics:Article Title: Characteristics of Medical Products Comprising Human Cells, Genes, or Tissues Developed in Japan and the European Union Compared via Public Assessment Reports Article Snippet: , Autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with retroviral vector that encodes for the human ADA cDNA sequence , Strimvelis® , Adenosine deaminase (ADA)-severe In Vitro:Article Title: Characteristics of Medical Products Comprising Human Cells, Genes, or Tissues Developed in Japan and the European Union Compared via Public Assessment Reports Article Snippet: , Autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with retroviral vector that encodes for the human ADA cDNA sequence , Strimvelis® , Adenosine deaminase (ADA)-severe In Vivo:Article Title: Characteristics of Medical Products Comprising Human Cells, Genes, or Tissues Developed in Japan and the European Union Compared via Public Assessment Reports Article Snippet: , Autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with retroviral vector that encodes for the human ADA cDNA sequence , Strimvelis® , Adenosine deaminase (ADA)-severe Drug discovery:Article Title: Characteristics of Medical Products Comprising Human Cells, Genes, or Tissues Developed in Japan and the European Union Compared via Public Assessment Reports Article Snippet: , Autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with retroviral vector that encodes for the human ADA cDNA sequence , Strimvelis® , Adenosine deaminase (ADA)-severe |